InvestorsHub Logo
Followers 114
Posts 6021
Boards Moderated 3
Alias Born 09/16/2009

Re: None

Friday, 09/29/2017 4:21:11 PM

Friday, September 29, 2017 4:21:11 PM

Post# of 837
doris over at the aols yahoo board has had some interesting insight over the years. Here is the text of her last post:

So how about this horse poo. The accountant in charge of writing checks for BARDA decided that aols 10150 is no good and put it under review, mind you this guy is not a scientist or doctor, BARDA has publicly refuted this guy, this is 2 or 3 PR's ago. Now the latest PR, has the National Institutes of Health,-National Institute of Allergy and Infectious Disease, completing the funding of 10150 that this pencil pusher has currently under review, 100% going around his decision. #$%$..."We appreciate the funding provided by BARDA to bring the development of AEOL 10150 as a medical countermeasure to Technology Readiness Level 7 and are encouraged that the National Institutes of Health-National Institute of Allergy and Infectious Disease is working with us to help fund the remaining work required for approval under the Animal Rule," stated John L. McManus, President and Chief Executive Officer of Aeolus Pharmaceuticals, Inc.


Email: sheepery@gmail.com